Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms

被引:76
|
作者
Pan, Bo [1 ]
Sun, Jing [1 ]
Liu, Ziyu [1 ]
Wang, Lingxiao [1 ]
Huo, Huixia [1 ]
Zhao, Yunfang [1 ]
Tu, Pengfei [1 ]
Xiao, Wei [2 ]
Zheng, Jiao [1 ]
Li, Jun [1 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Medica, Beijing 100029, Peoples R China
[2] Jiangsu Kanion Parmaceut Co Ltd, Lianyungang 222001, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Longxuetongluo Capsule; Oxygen-glucose deprivation/reperfusion; Apoptosis; Endoplasmic reticulum stress; DRAGONS BLOOD; CELL-DEATH; REPERFUSION INJURY; SIGNALING PATHWAYS; APOPTOSIS; ISCHEMIA; ACTIVATION; BRAIN; DERIVATIVES; CASPASE-3;
D O I
10.1016/j.jare.2021.01.016
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Longxuetongluo Capsule (LTC) is wildly applied to treat ischemic stroke in clinical practice in China. However, the pharmacological mechanism of LTC on ischemic stroke is still unstated. Objective: Our research was designed to study the protective effect of LTC against cerebral ischemia-reperfusion (I/R) injury and reveal the underlying mechanism both in vivo and in vitro. Methods: PC12 cells treated with glucose deprivation/reperfusion (OGD/R) were used to simulate in vitro ischemia/reperfusion (I/R) injury. The cell viability, apoptosis rate, and protein expressions of PC12 cells were evaluated. In vivo validation of the protective effect of LTC was carried out by middle cerebral artery occlusion (MCAO)/reperfusion treatment, and the underlying mechanism of its anti-apoptosis ability was further revealed by immunohistochemistry staining and Western blotting. Results: In the current study, we observed that LTC effectively inhibited oxygen-glucose deprivation/reperfusion (OGD/R) induced apoptosis of PC12 cells through suppressing the cleavage of poly ADP-ribose polymerase (PARP), caspase-3, and caspase-9. Further investigation revealed that OGD/R insult remarkably triggered the endoplasmic reticulum stress responses (ER stress) to induce PC12 cell apoptosis. LTC treatment alleviated OGD/R induced ER stress by inhibiting the activation of protein kinase RNA (PKR)-like ER kinase (PERK)/eukaryotic translation initiation factor 2 (eIF2 alpha) and inositol requiring enzyme 1 (IRE1)/tumor necrosis factor receptor-associated factor 2 (TRAF2) pathways. Additionally, LTC also restrained the OGD/R-induced PC12 cell apoptosis by reversing the activated mitogen-activated protein kinase (MAPK) through IRE1/TRAF2 pathway. Animal studies demonstrated LTC significantly restricted the infarct region induced by middle cerebral artery occlusion (MCAO)/reperfusion, the activation of ER stress and apoptosis of neuronal cells had also been suppressed by LTC in the penumbra region. Conclusion: LTC protects the cerebral neuronal cell against ischemia/reperfusion injury through ER stress and MAPK-mediated mechanisms. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University.
引用
收藏
页码:215 / 225
页数:11
相关论文
共 50 条
  • [1] Acupuncture protects against cerebral ischemia–reperfusion injury via suppressing endoplasmic reticulum stress-mediated autophagy and apoptosis
    Xiaowei Sun
    Hao Liu
    Zhongren Sun
    Beng Zhang
    Xinyu Wang
    Tingting Liu
    Tingting Pan
    Ying Gao
    Xicheng Jiang
    Hongtao Li
    Molecular Medicine, 2020, 26
  • [2] Melatonin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress
    Lin, Yu Wen
    Chen, Tsung Ying
    Hung, Chia Yang
    Tai, Shih Huang
    Huang, Sheng Yang
    Chang, Che Chao
    Hung, Hsin Yi
    Lee, E. Jian
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (01) : 182 - 192
  • [3] Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia/reperfusion injury
    Xuemei Zhao
    Lin Zhu
    Danyang Liu
    Tianyan Chi
    Xuefei Ji
    Peng Liu
    Xuexue Yang
    Xinxin Tian
    Libo Zou
    Apoptosis, 2019, 24 : 157 - 167
  • [4] Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia/reperfusion injury
    Zhao, Xuemei
    Zhu, Lin
    Liu, Danyang
    Chi, Tianyan
    Ji, Xuefei
    Liu, Peng
    Yang, Xuexue
    Tian, Xinxin
    Zou, Libo
    APOPTOSIS, 2019, 24 (1-2) : 157 - 167
  • [5] Acupuncture protects against cerebral ischemia-reperfusion injury via suppressing endoplasmic reticulum stress-mediated autophagy and apoptosis
    Sun, Xiaowei
    Liu, Hao
    Sun, Zhongren
    Zhang, Beng
    Wang, Xinyu
    Liu, Tingting
    Pan, Tingting
    Gao, Ying
    Jiang, Xicheng
    Li, Hongtao
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [6] Neuroprotective effects of atorvastatin against cerebral ischemia/reperfusion injury through the inhibition of endoplasmic reticulum stress
    Jian-wen Yang
    Zhi-ping Hu
    NeuralRegenerationResearch, 2015, 10 (08) : 1239 - 1244
  • [7] Neuroprotective effects of atorvastatin against cerebral ischemia/reperfusion injury through the inhibition of endoplasmic reticulum stress
    Yang, Jian-wen
    Hu, Zhi-ping
    NEURAL REGENERATION RESEARCH, 2015, 10 (08) : 1239 - 1244
  • [8] Sappanone A Protects Against Inflammation, Oxidative Stress and Apoptosis in Cerebral Ischemia-Reperfusion Injury by Alleviating Endoplasmic Reticulum Stress
    Meihua Wang
    Zhilin Chen
    Lei Yang
    Lei Ding
    Inflammation, 2021, 44 : 934 - 945
  • [9] Sappanone A Protects Against Inflammation, Oxidative Stress and Apoptosis in Cerebral Ischemia-Reperfusion Injury by Alleviating Endoplasmic Reticulum Stress
    Wang, Meihua
    Chen, Zhilin
    Yang, Lei
    Ding, Lei
    INFLAMMATION, 2021, 44 (03) : 934 - 945
  • [10] Melastoma dodecandrum lour. Protects against cerebral ischemia-reperfusion - reperfusion injury by ameliorating oxidative stress and endoplasmic reticulum stress
    Liu, Shuang
    Zhang, Xiaoqin
    Lin, Bingfeng
    Mao, Jiale
    Zhan, Jianhu
    Li, Yanyan
    Zhou, Jiwang
    Wang, Nani
    Qiu, Weiwen
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 336